Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study

Overview of attention for article published in Journal of Hematology & Oncology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,706 followers.

RT @NEpperla: @PallawiTorkaMD @jonathonbcohen @lymphomatic @nancybartlettMD @NatalieGroverMD @StefanBartaMD https://t.co/G6pzX9Flug

13 Dec 2022

Reply Repost Favourite

@PallawiTorkaMD @jonathonbcohen @lymphomatic @nancybartlettMD @NatalieGroverMD @StefanBartaMD https://t.co/G6pzX9Flug

20 Jul 2022

Reply Repost Favourite

Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study #lymphoma #lymsm https://t.co/gSrQfNJ7eu

17 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.